Asset Details
Do you wish to reserve the book?
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Do you wish to request the book?
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
2020
Overview
To evaluate the clinical implementation of pharmacotherapy recommendations for chronic obstructive pulmonary disease (COPD) based on the Global Initiative for chronic obstructive lung disease (GOLD) guidelines, in a longitudinal setting.
This is a sub-analysis of a prospective, non-interventional cohort study including patients with confirmed mild-to-very-severe COPD from seven pulmonary outpatient clinics in Switzerland. Follow-up visits took place annually for up to 7 years, from October 2010 until December 2016. For each visit, we evaluated the compliance of the prescribed pharmacotherapy with the concurrently valid GOLD guideline. We investigated whether step-ups or step-downs in GOLD stage or risk-group were accompanied by concordant changes in prescribed medication. Groups were compared via ANOVA.
Data of 305 patients (62±7 years, 66% men) were analysed. In 59.1% of visits, the prescribed medication conformed to the respective valid GOLD-guideline. Patients with very severe COPD were most likely to receive pharmacotherapy in compliance with guidelines. Step-ups and step-downs in risk group, requiring escalation, or de-escalation of pharmacotherapy, were noticed in 24 and 43 follow-up visits, respectively. Step-ups were adequately implemented in 4 (16.7%) and step-downs in six cases (14.0%).
The compliance of COPD-pharmacotherapy with GOLD-guidelines is suboptimal, especially in lower risk groups. The high rates of missed out treatment-adjustments suggest that the familiarity of physicians with guidelines leaves room for improvement.
Publisher
Dove Medical Press Limited,Dove Medical Press Ltd,Dove Press,Dove,Dove Medical Press
Subject
/ Analysis
/ Chronic obstructive lung disease
/ Chronic obstructive pulmonary disease
/ Clinics
/ Consent
/ Costs
/ Diseases
/ Dyspnea
/ Female
/ Global Initiative for Chronic Obstructive Lung Disease guidelines
/ Guideline Adherence - statistics & numerical data
/ Humans
/ Male
/ Non-pharmacological intervention
/ Patients
/ Pulmonary Disease, Chronic Obstructive - diagnosis
/ Pulmonary Disease, Chronic Obstructive - drug therapy
/ Steroids
